(MENAFN- America News Hour)
Research Nester published a report titled “Migraine Nasal Spray Market : Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global migraine nasal spray market in terms of market segmentation by drug type, distribution channel, dosage, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.
The global migraine nasal spray market is predicted to acquire a notable CAGR over the forecast period, i.e., 2022-2031. The market is segmented on the basis of drug type into ergotamine dihydroergotamine, ketorolac, and zolmitriptan, out of which, the zolmitriptan segment is expected to acquire a significant share in the market over the forecast period, owing to the lesser cost and high efficiency of the drug zolmitriptan.
Get a PDF Sample For More Detailed Market Insights:
The global migraine nasal spray market is estimated to grow on the back of the rising prevalence migraine due to higher incidences of stress, sleep deprivation, anxiety, and depression. Moreover, hormonal changes in women make migraine more pervasive than in men. As migraine hampers productivity, people seek therapeutic relief measures for acute migraine pain, which is estimated to increase the demand for migraine nasal sprays. As migraine is the third most common illness worldwide and has approximately 1 billion patients worldwide, the market is estimated to witness unprecedented growth.
Regionally, the global migraine nasal spray market is segmented by geography into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is expected to gain a notable share over the forecast period, owing to the presence of good healthcare infrastructure, and widespread availability of medicines in the region. On the other hand, the market in the Asia Pacific region is also estimated to witness boom over the forecast period, owing to the rising population and increased health awareness.
The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Rising Number of Migraine Patients Worldwide to Boost the Market Growth
Migraine causes acute pain to the patient and hampers productivity. Moreover, migraine is prevalent in every age group, and people are seeking remedies. The migraine nasal spray is a convenient and effective method for reducing excruciating migraine pain, which us estimated to boost the global migraine nasal spray market growth.
However, the side effects like irritated throat, dry nose, and others, caused by nasal spray usage are expected to operate as a key restraint to the growth of the global migraine nasal spray market over the forecast period.
This report also provides the existing competitive scenario of some of the key players in the global migraine nasal spray market which include company profiling of Upsher-Smith Laboratories, LLC, AstraZeneca plc, Cipla Inc, GlaxoSmithKline plc, Dr. Reddy's Laboratories Ltd., Leucadia Pharmaceuticals (Custopharm, Inc), Assertio Therapeutics, Inc, Impel Neuro Pharma. Inc, Tonix Pharmaceuticals Holding Corp., and Amneal Pharmaceuticals LLC. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts a detailed overview of the global migraine nasal spray market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
For More Information About This Report Visit:
About Us
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Henry Lucas
Henry Lucas is an experienced Industry researcher with more than 10 years of experience and he has a great interest and knowledge about the Business industry in research Strategy, Strategic Planning, new innovations and technology.
MENAFN16052022004545010068ID1104218728
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.